MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Zaponex 100mg tablets (Leyden Delta B.V.) and Denzapine 100mg tablets (Britannia Pharmaceuticals Ltd).

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Denzapine 200mg tablets (Britannia Pharmaceuticals Ltd).

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Zaponex 25mg tablets (Leyden Delta B.V.) and Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd).

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Denzapine 50mg tablets (Britannia Pharmaceuticals Ltd).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 250mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 250mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 250mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 500mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 500mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Max 7 days in MCA.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Depakote 500mg gastro-resistant tablets (Sanofi).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 30mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 60mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.